nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—TNNC1—adrenal cortex—polycystic ovary syndrome	0.0454	0.0805	CbGeAlD
Levosimendan—TNNC1—endometrium—polycystic ovary syndrome	0.0405	0.0719	CbGeAlD
Levosimendan—TNNC1—pituitary gland—polycystic ovary syndrome	0.0367	0.065	CbGeAlD
Levosimendan—TNNC1—adipose tissue—polycystic ovary syndrome	0.0365	0.0648	CbGeAlD
Levosimendan—TNNC1—Striated Muscle Contraction—DMD—polycystic ovary syndrome	0.0344	0.0789	CbGpPWpGaD
Levosimendan—KCNJ8—adrenal cortex—polycystic ovary syndrome	0.0341	0.0604	CbGeAlD
Levosimendan—TNNC1—adrenal gland—polycystic ovary syndrome	0.0328	0.0581	CbGeAlD
Levosimendan—KCNJ8—endometrium—polycystic ovary syndrome	0.0304	0.0539	CbGeAlD
Levosimendan—PDE3A—cGMP effects—PDE3B—polycystic ovary syndrome	0.0303	0.0695	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—DMD—polycystic ovary syndrome	0.0292	0.067	CbGpPWpGaD
Levosimendan—KCNJ8—uterus—polycystic ovary syndrome	0.028	0.0497	CbGeAlD
Levosimendan—KCNJ8—pituitary gland—polycystic ovary syndrome	0.0275	0.0488	CbGeAlD
Levosimendan—KCNJ11—Type II diabetes mellitus—INS-IGF2—polycystic ovary syndrome	0.0275	0.0631	CbGpPWpGaD
Levosimendan—KCNJ8—adipose tissue—polycystic ovary syndrome	0.0274	0.0486	CbGeAlD
Levosimendan—KCNJ8—adrenal gland—polycystic ovary syndrome	0.0246	0.0436	CbGeAlD
Levosimendan—PDE3A—Nitric oxide stimulates guanylate cyclase—PDE3B—polycystic ovary syndrome	0.0241	0.0552	CbGpPWpGaD
Levosimendan—TNNC1—Muscle contraction—DMD—polycystic ovary syndrome	0.0231	0.053	CbGpPWpGaD
Levosimendan—KCNJ8—female gonad—polycystic ovary syndrome	0.0229	0.0407	CbGeAlD
Levosimendan—KCNJ8—vagina—polycystic ovary syndrome	0.0228	0.0404	CbGeAlD
Levosimendan—PDE3A—adipose tissue—polycystic ovary syndrome	0.0219	0.0388	CbGeAlD
Levosimendan—KCNJ8—endocrine gland—polycystic ovary syndrome	0.0213	0.0378	CbGeAlD
Levosimendan—KCNJ11—adrenal gland—polycystic ovary syndrome	0.02	0.0355	CbGeAlD
Levosimendan—PDE3A—adrenal gland—polycystic ovary syndrome	0.0196	0.0348	CbGeAlD
Levosimendan—KCNJ11—female gonad—polycystic ovary syndrome	0.0187	0.0331	CbGeAlD
Levosimendan—PDE3A—female gonad—polycystic ovary syndrome	0.0183	0.0325	CbGeAlD
Levosimendan—KCNJ11—endocrine gland—polycystic ovary syndrome	0.0174	0.0308	CbGeAlD
Levosimendan—PDE3A—endocrine gland—polycystic ovary syndrome	0.017	0.0302	CbGeAlD
Levosimendan—KCNJ11—Type II diabetes mellitus—INSR—polycystic ovary syndrome	0.0139	0.0319	CbGpPWpGaD
Levosimendan—KCNJ11—Type II diabetes mellitus—ADIPOQ—polycystic ovary syndrome	0.0116	0.0266	CbGpPWpGaD
Levosimendan—KCNJ11—Type II diabetes mellitus—SLC2A4—polycystic ovary syndrome	0.011	0.0251	CbGpPWpGaD
Levosimendan—PDE3A—Platelet homeostasis—PDE3B—polycystic ovary syndrome	0.00938	0.0215	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—IGFBP1—polycystic ovary syndrome	0.00931	0.0213	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—LHCGR—polycystic ovary syndrome	0.00805	0.0185	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.00781	0.0179	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—TFRC—polycystic ovary syndrome	0.0074	0.017	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—PDE3B—polycystic ovary syndrome	0.00647	0.0148	CbGpPWpGaD
Levosimendan—KCNJ11—Type II diabetes mellitus—IRS1—polycystic ovary syndrome	0.00643	0.0147	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—FSHR—polycystic ovary syndrome	0.00589	0.0135	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—ADRB3—polycystic ovary syndrome	0.00519	0.0119	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—LHB—polycystic ovary syndrome	0.00513	0.0118	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.00496	0.0114	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—SCT—polycystic ovary syndrome	0.0048	0.011	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NR3C1—polycystic ovary syndrome	0.00465	0.0107	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.00441	0.0101	CbGpPWpGaD
Levosimendan—PDE3A—Platelet homeostasis—GNAS—polycystic ovary syndrome	0.00376	0.00863	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00366	0.00839	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.00357	0.00818	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	0.00353	0.0081	CbGpPWpGaD
Levosimendan—KCNJ11—Regulation of insulin secretion—GNAS—polycystic ovary syndrome	0.00337	0.00773	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—DLG4—polycystic ovary syndrome	0.00323	0.00742	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—GP1BB—polycystic ovary syndrome	0.00313	0.00718	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—ADRB2—polycystic ovary syndrome	0.0028	0.00642	CbGpPWpGaD
Levosimendan—KCNJ11—Integration of energy metabolism—GNAS—polycystic ovary syndrome	0.00265	0.00608	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—GNAS—polycystic ovary syndrome	0.0026	0.00596	CbGpPWpGaD
Levosimendan—KCNJ11—Regulation of insulin secretion—INS—polycystic ovary syndrome	0.00226	0.00518	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PDE3B—polycystic ovary syndrome	0.0021	0.00482	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00198	0.00454	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—RACGAP1—polycystic ovary syndrome	0.0018	0.00412	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—NPB—polycystic ovary syndrome	0.0018	0.00412	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00179	0.0041	CbGpPWpGaD
Levosimendan—KCNJ11—Integration of energy metabolism—INS—polycystic ovary syndrome	0.00178	0.00407	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00175	0.00402	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00175	0.00402	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.00175	0.00401	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00173	0.00397	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.00171	0.00393	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00165	0.00379	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00165	0.00379	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00163	0.00373	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00155	0.00354	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—DLG4—polycystic ovary syndrome	0.00153	0.00351	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.0015	0.00344	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.0015	0.00344	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.0015	0.00344	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00146	0.00335	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NMNAT3—polycystic ovary syndrome	0.00141	0.00323	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.0014	0.00322	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00136	0.00312	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00133	0.00304	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00133	0.00304	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—LPCAT2—polycystic ovary syndrome	0.00129	0.00295	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SUOX—polycystic ovary syndrome	0.00129	0.00295	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00121	0.00279	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00121	0.00277	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00121	0.00276	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ISYNA1—polycystic ovary syndrome	0.0012	0.00275	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.00118	0.00272	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00111	0.00254	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PLAT—polycystic ovary syndrome	0.0011	0.00252	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.0011	0.00252	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00106	0.00244	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NPB—polycystic ovary syndrome	0.00106	0.00243	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00105	0.00241	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00103	0.00236	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AKR1C2—polycystic ovary syndrome	0.00102	0.00234	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TEAD2—polycystic ovary syndrome	0.00102	0.00234	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.001	0.0023	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000986	0.00226	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000967	0.00222	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00096	0.0022	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000955	0.00219	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00094	0.00216	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000934	0.00214	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000895	0.00205	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000886	0.00203	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000886	0.00203	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000854	0.00196	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PNPLA2—polycystic ovary syndrome	0.000854	0.00196	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—GNAS—polycystic ovary syndrome	0.000843	0.00193	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000829	0.0019	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SRD5A1—polycystic ovary syndrome	0.000809	0.00186	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000805	0.00185	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000783	0.00179	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—STAR—polycystic ovary syndrome	0.000772	0.00177	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000763	0.00175	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000712	0.00163	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000694	0.00159	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HMMR—polycystic ovary syndrome	0.000688	0.00158	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HSD3B1—polycystic ovary syndrome	0.000656	0.0015	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000649	0.00149	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000631	0.00145	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00061	0.0014	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—LHB—polycystic ovary syndrome	0.000599	0.00137	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000593	0.00136	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HSD3B2—polycystic ovary syndrome	0.000585	0.00134	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FST—polycystic ovary syndrome	0.000578	0.00133	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000575	0.00132	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000571	0.00131	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AKR1C1—polycystic ovary syndrome	0.000567	0.0013	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000564	0.00129	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000552	0.00126	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IGF1—polycystic ovary syndrome	0.000546	0.00125	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—AKT2—polycystic ovary syndrome	0.000546	0.00125	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000534	0.00122	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000533	0.00122	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000529	0.00121	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000522	0.0012	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SULT2A1—polycystic ovary syndrome	0.000521	0.0012	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000519	0.00119	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—RRM2—polycystic ovary syndrome	0.000505	0.00116	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000504	0.00116	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000496	0.00114	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000492	0.00113	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—YAP1—polycystic ovary syndrome	0.000487	0.00112	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000484	0.00111	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NAMPT—polycystic ovary syndrome	0.000468	0.00107	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP11A1—polycystic ovary syndrome	0.000462	0.00106	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000459	0.00105	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000453	0.00104	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AKR1C3—polycystic ovary syndrome	0.000436	0.001	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000433	0.000992	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP17A1—polycystic ovary syndrome	0.000429	0.000984	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000411	0.000943	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000405	0.000928	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000401	0.000919	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000373	0.000854	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000373	0.000854	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TH—polycystic ovary syndrome	0.000372	0.000852	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC2A4—polycystic ovary syndrome	0.000361	0.000829	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000359	0.000823	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—VEGFA—polycystic ovary syndrome	0.000357	0.000818	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000355	0.000815	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000347	0.000795	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000345	0.000791	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP19A1—polycystic ovary syndrome	0.00034	0.000779	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000328	0.000752	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000326	0.000747	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000325	0.000745	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000313	0.000718	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000308	0.000707	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GNAS—polycystic ovary syndrome	0.000303	0.000695	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NCOR1—polycystic ovary syndrome	0.000289	0.000662	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000286	0.000656	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP1A1—polycystic ovary syndrome	0.000274	0.000628	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000272	0.000625	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000267	0.000613	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MTHFR—polycystic ovary syndrome	0.000255	0.000585	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000229	0.000525	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LEP—polycystic ovary syndrome	0.000224	0.000514	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPARG—polycystic ovary syndrome	0.000207	0.000475	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—POMC—polycystic ovary syndrome	0.000204	0.000468	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—INS—polycystic ovary syndrome	0.000203	0.000466	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IRS1—polycystic ovary syndrome	0.0002	0.000458	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—POMC—polycystic ovary syndrome	0.000193	0.000441	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—INS—polycystic ovary syndrome	0.000191	0.000439	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000185	0.000425	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000185	0.000424	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000176	0.000403	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000142	0.000325	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000121	0.000277	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6—polycystic ovary syndrome	8.37e-05	0.000192	CbGpPWpGaD
